• Covid-19 Coronavirus Spain live |

    The US gives full approval to the use of Pfizer's vaccine

  • Health The weakening of T cells, a possible origin of the inflammatory syndrome sequela of Covid-19 in children

The Food and Drug Administration

US

(

FDA

, in English) gave Monday its full approval to the vaccine

Covid-19

to

Pfizer

, the first serum of this type in the country you get has a

green light full of the regulator, since until now it had only of "emergency".

This was reported by the

FDA

in a statement, where its acting commissioner, Janet Woodcock, stressed that it is a "milestone" in the fight against the pandemic.

Following this approval, people "can be very confident that this

vaccine

meets the highest standards of safety, effectiveness, and build quality that the FDA requires for a (fully) approved product," Woodcock said.

The head of the FDA was hopeful that the full approval will overcome the distrust of some people towards the serums against

Covid-19

.

"Today's milestone brings us one step closer to changing the course of the pandemic," Woodcock said.

The vaccine was cleared for emergency use in the

US

.

in mid-December for those over 16 years of age, and it was extended in May for those over twelve years of age.

Full approval applies only to those 16 and older, as

Pfizer

has to provide more data on the use of the vaccine in children between the ages of 12 and 15 to achieve full authorization, which could take months.

Emergency clearances can be used by the

FDA

during health emergencies to provide access to medical products that can be effective in preventing, diagnosing, or treating disease.

Unlike an approval for emergency use, the full authorization lasts indefinitely unless some kind of unexpected side effect develops.

To achieve this type of approval, the company must provide extensive data on the manufacturing process and is subject to thorough

FDA

inspections

.

The

US

authorities

.

they hope that with full approval the immunization rate in the country will increase.

It may also encourage universities, companies and other institutions to require the vaccination record.

More than 170 million Americans in the US are fully vaccinated against

Covid-19

, of which more than 92 million have received serum from

Pfizer

.

The

FDA

is reviewing the information provided by

Moderna

, the other pharmaceutical company that has developed a messenger-RNA vaccine, like

Pfizer's

, to obtain full approval, as it only has emergency use approval.

The decision could take weeks.

Johnson & Johnson, which has developed the third vaccine to be approved for emergency use in the US (in this case from an adenovirus, like traditional vaccines), is expected to apply soon for full authorization.

This Monday's decision by the

FDA

is released as cases and hospitalizations have soared in the last month due to the expansion of the

delta variant

in the

US

.

The

FDA is

also now reviewing the possibility of giving a booster dose of the

Pfizer

and

Moderna

vaccines

to already immunized people, which the Government wants to start administering as of September 20 due to the spread of the delta variant

According to the criteria of The Trust Project

Know more

  • USA

  • Covid 19

  • Vaccines

If delta is as contagious as chickenpox, do the rules against Covid change?

Covid-19 This is how a side effect of an anti-Covid vaccine is recorded

Covid-19Coronavirus Spain live |

Spain aspires to reach 70% of the population vaccinated with the full schedule next week

See links of interest

  • Last News

  • Work calendar

  • Home THE WORLD TODAY

  • Master Investigation Journalism

  • Direct afghanistan

  • Atlético de Madrid - Elche

  • Napoli - Venezia

  • Rome - Fiorentina

  • Nice - Marseille

  • Raise - Real Madrid